- Primoris Services Corp’s (NASDAQ:PRIM) Energy/Renewables Segment has received two new solar awards with a combined value of over $120 million. The scope includes all civil, electrical, and mechanical work.
- The first award is for the engineering, procurement, and construction of a utility-scale solar facility in the Southwest. Initial construction on the project will begin in 3Q21, with completion expected in 3Q22.
- The second award is for the engineering, procurement, and construction of a utility-scale solar facility in the Midwest. Initial construction will begin in 3Q21, with completion expected in 2Q22.
- Primoris executed three contracts last week for a combined total of over $220 million, adding to the Energy/Renewables segment backlog.
- Price Action: PRIM shares are trading lower by 1.31% at $24.90 on the last check Thursday.
Daré Bioscience Initiates Phase 1/2 Clinical Study Of DARE-HRT1
Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced the initiation of a Phase 1/2 clinical study of DARE-HRT1.
DARE-HRT1 is a novel intravaginal ring (IVR)
